fda approves first oral glp-1 obesity drug august 1 2025 US accepts Novo Nordisk's application for Wegovy for weight loss Lilly launches GLP-1 pill, kicking

These side effects usually subside on their own within a few days

This stopped my hair loss in 2 weeks." One of the women in my group posted this "It's the only thing that actually worked," wrote Jennifer from Texas

Cosmetic companies can better control the quality of their finished products if they choose a source that gives them scientific documents, such as purity tests and batch information

However, several developments may affect your options: OSA coverage continues for Medicare members meeting criteria (AHI 15, BMI 30, no diabetes) Oral Wegovy launched January 2026 Available via NovoCare at $149-299/month, no injection required Medicare $50/month benefit Expected mid-2026 for qualifying obesity medications (may not include Humana Medicare Advantage) Medicaid expansion Some states adding GLP-1 coverage

Myelin plasticity in the central nervous system